Drug Profile
Heparin oral - Emisphere
Alternative Names: Elaprin; Emisphere oral heparinLatest Information Update: 14 Dec 2020
Price :
$50
*
At a glance
- Originator Emisphere Technologies
- Class Antithrombotics; Heparins
- Mechanism of Action Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Deep vein thrombosis
Most Recent Events
- 08 Dec 2020 Emisphere Technologies has been acquired by Novo Nordisk
- 20 Oct 2009 No development reported - Phase-III for Deep vein thrombosis in Australia (PO)
- 20 Oct 2009 No development reported - Phase-III for Deep vein thrombosis in Canada (PO)